152 related articles for article (PubMed ID: 26000477)
21. The RAF-MEK-ERK pathway: targeting ERK to overcome obstacles to effective cancer therapy.
Yu Z; Ye S; Hu G; Lv M; Tu Z; Zhou K; Li Q
Future Med Chem; 2015; 7(3):269-89. PubMed ID: 25826360
[TBL] [Abstract][Full Text] [Related]
22. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
[TBL] [Abstract][Full Text] [Related]
23. A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation.
Simanshu DK; Morrison DK
Cancer Discov; 2022 Apr; 12(4):899-912. PubMed ID: 35046094
[TBL] [Abstract][Full Text] [Related]
24. Regulation and role of Raf-1/B-Raf heterodimerization.
Rushworth LK; Hindley AD; O'Neill E; Kolch W
Mol Cell Biol; 2006 Mar; 26(6):2262-72. PubMed ID: 16508002
[TBL] [Abstract][Full Text] [Related]
25. Functional analysis of mutations within the kinase activation segment of B-Raf in human colorectal tumors.
Ikenoue T; Hikiba Y; Kanai F; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Aragaki J; Matsumura M; Kawabe T; Omata M
Cancer Res; 2003 Dec; 63(23):8132-7. PubMed ID: 14678966
[TBL] [Abstract][Full Text] [Related]
26. NBS1 is required for IGF-1 induced cellular proliferation through the Ras/Raf/MEK/ERK cascade.
Hematulin A; Sagan D; Eckardt-Schupp F; Moertl S
Cell Signal; 2008 Dec; 20(12):2276-85. PubMed ID: 18793719
[TBL] [Abstract][Full Text] [Related]
27. A loss-of-function screen reveals Ras- and Raf-independent MEK-ERK signaling during Chlamydia trachomatis infection.
Gurumurthy RK; Mäurer AP; Machuy N; Hess S; Pleissner KP; Schuchhardt J; Rudel T; Meyer TF
Sci Signal; 2010 Mar; 3(113):ra21. PubMed ID: 20234004
[TBL] [Abstract][Full Text] [Related]
28. B-Raf and C-Raf signaling investigated in a simplified model of the mitogenic kinase cascade.
Robubi A; Mueller T; Fueller J; Hekman M; Rapp UR; Dandekar T
Biol Chem; 2005 Nov; 386(11):1165-71. PubMed ID: 16307482
[TBL] [Abstract][Full Text] [Related]
29. Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia.
Zebisch A; Staber PB; Delavar A; Bodner C; Hiden K; Fischereder K; Janakiraman M; Linkesch W; Auner HW; Emberger W; Windpassinger C; Schimek MG; Hoefler G; Troppmair J; Sill H
Cancer Res; 2006 Apr; 66(7):3401-8. PubMed ID: 16585161
[TBL] [Abstract][Full Text] [Related]
30. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.
Sasaki A; Taketomi T; Kato R; Saeki K; Nonami A; Sasaki M; Kuriyama M; Saito N; Shibuya M; Yoshimura A
Nat Cell Biol; 2003 May; 5(5):427-32. PubMed ID: 12717443
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Raf-1 by direct feedback phosphorylation.
Dougherty MK; Müller J; Ritt DA; Zhou M; Zhou XZ; Copeland TD; Conrads TP; Veenstra TD; Lu KP; Morrison DK
Mol Cell; 2005 Jan; 17(2):215-24. PubMed ID: 15664191
[TBL] [Abstract][Full Text] [Related]
32. Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells.
Takezawa K; Okamoto I; Yonesaka K; Hatashita E; Yamada Y; Fukuoka M; Nakagawa K
Cancer Res; 2009 Aug; 69(16):6515-21. PubMed ID: 19638574
[TBL] [Abstract][Full Text] [Related]
33. Depletion of intracellular zinc induced apoptosis in cultured hippocampal neurons through Raf/MEK/ERK pathways.
Pang W; Lu H; Hu YD; Yang HP; Leng X; Jiang YG
Nutr Neurosci; 2012 Jan; 15(1):18-24. PubMed ID: 22305649
[TBL] [Abstract][Full Text] [Related]
34. Coordinating ERK/MAPK signalling through scaffolds and inhibitors.
Kolch W
Nat Rev Mol Cell Biol; 2005 Nov; 6(11):827-37. PubMed ID: 16227978
[TBL] [Abstract][Full Text] [Related]
35. Raf phosphorylation: one step forward and two steps back.
Dumaz N; Marais R
Mol Cell; 2005 Jan; 17(2):164-6. PubMed ID: 15664184
[TBL] [Abstract][Full Text] [Related]
36. ERK signalling and oncogene transformation are not impaired in cells lacking A-Raf.
Mercer K; Chiloeches A; Hüser M; Kiernan M; Marais R; Pritchard C
Oncogene; 2002 Jan; 21(3):347-55. PubMed ID: 11821947
[TBL] [Abstract][Full Text] [Related]
37. The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration.
Klingauf M; Beck M; Berge U; Turgay Y; Heinzer S; Horvath P; Kroschewski R
Biol Cell; 2013 Feb; 105(2):91-107. PubMed ID: 23157514
[TBL] [Abstract][Full Text] [Related]
38. Hyperactive Ras in developmental disorders and cancer.
Schubbert S; Shannon K; Bollag G
Nat Rev Cancer; 2007 Apr; 7(4):295-308. PubMed ID: 17384584
[TBL] [Abstract][Full Text] [Related]
39. Fibronectin-induced proliferation in thyroid cells is mediated by alphavbeta3 integrin through Ras/Raf-1/MEK/ERK and calcium/CaMKII signals.
Illario M; Cavallo AL; Monaco S; Di Vito E; Mueller F; Marzano LA; Troncone G; Fenzi G; Rossi G; Vitale M
J Clin Endocrinol Metab; 2005 May; 90(5):2865-73. PubMed ID: 15687337
[TBL] [Abstract][Full Text] [Related]
40. RAF protein-serine/threonine kinases: structure and regulation.
Roskoski R
Biochem Biophys Res Commun; 2010 Aug; 399(3):313-7. PubMed ID: 20674547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
